Newsroom
CONTACTS
Media: Sunny Uberoi, 212.994.8206
Investors: Shalini Sharp, 800.962.2436
Recent Press Releases
| DATE |
TITLE (click to view) |
| June 25, 2009 | Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma |
| June 17, 2009 | Antigenics’ QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline’s Malaria Vaccine |
| June 15, 2009 | Tim Rothwell Joins Antigenics' Board of Directors |
| June 1, 2009 | Antigenics Presents Positive Oncophage® Interim Survival Data at ASCO |
| May 27, 2009 | Antigenics To Webcast 2009 Annual Shareholders Meeting |
| May 7, 2009 | Antigenics Reports First Quarter 2009 Financial Results |
| May 4, 2009 | Antigenics to Report First Quarter 2009 Financial Results on May 7, 2009; Conference Call to Follow |
| April 30, 2009 | Antigenics Regains NASDAQ Compliance |
| April 29, 2009 | FDA Grants Orphan Drug Designation to Oncophage for the Treatment of Glioma |
| March 12, 2009 | Antigenics’ Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer |
| |
More news releases » |
|
|
Click to download the essential documents about Antigenics.
(1 MB .zip) |
|
|
